VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
VACCINEX, INC.
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026
- Market cap
- $3.22M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Apr 2, 2024(first seen in filings) | 1-for-14 reverse | Earlier per-share figures multiplied by 14 |
| Feb 20, 2024 | 1-for-14 reverse | Earlier per-share figures multiplied by 14 |
| Nov 13, 2023(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Sep 26, 2023 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |